XML 32 R22.htm IDEA: XBRL DOCUMENT v3.19.1
Revenue Recognition (Tables)
3 Months Ended
Mar. 31, 2019
Disaggregation of Revenue
Revenues for the three months ended March 31, 2019 and 2018 were as follows:
 
 
 
Three Months Ended
March 31,
 
 
Increase/ (Decrease)
 
 
 
2019
 
 
2018
 
 
$ Change
 
 
% Change
 
 
 
(Amounts in thousands)
 
 
 
 
 
 
 
Product Revenue
 
$
60,612
 
 
$
44,799
 
 
$
15,813
 
 
 
35.3
%
Royalty and other income
 
 
22
 
 
 
31
 
 
 
(9
)
 
 
(29.0
%)
Total revenue
 
$
60,634
 
 
$
44,830
 
 
$
15,804
 
 
 
35.3
%
Revenue from Significant Customers
Revenue from significant customers is as follows:
 
 
 
Three Months Ended
March 31,
 
 
 
2019
 
 
2018
 
 
 
(Amounts in thousands)
 
MilliporeSigma
 
$
9,407
 
 
$
6,465
 
GE Healthcare
 
$
7,666
 
 
$
7,717
 
Summary of Receivables and Deferred Revenue from Contracts with Customers
The following table provides information about receivables and deferred revenues from contracts with customers as of March 31, 2019 (amounts in thousands):
 
 
 
2019
 
Balances from contracts with customers only:
 
 
 
 
Accounts receivable
 
$
39,341
 
Deferred revenue (included in accrued liabilities in the consolidated balance sheets)
 
 
1,287
 
Revenue recognized during the three-month period ending March 31, 2019 relating to:
 
 
 
 
The beginning deferred revenue balance
 
$
878
 
Changes in pricing related to products or services satisfied in previous periods